# Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

> **NCT00989014** · PHASE2 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 122 (actual)

## Conditions studied

- Erythematotelangiectatic Rosacea

## Interventions

- **DRUG:** CD07805/47
- **DRUG:** CD07805/47
- **DRUG:** CD07805/47
- **DRUG:** CD07805/47 placebo

## Key facts

- **NCT ID:** NCT00989014
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00989014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00989014, "Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00989014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*